Pfizer Inc. pay settlement due to the marketing of an illegal drug.

Drug makers, Pfizer Inc. has had to agree on the payment of $14.5 million to the government over the wrongful advertising of a drug for an overactive bladder condition.



This settlement comes after $2.3 billion was paid out in 2009 for criminal charges. Many of these involved claims by civilians and as their fourth settlement proceeding in a year, it involved with the illegal marketing of medicine to about 13 large sellers, including Viagra. The 2009 settlement sparked the agreement that the Pfizer had to be monitored for the following five years with regards to violating the law and continuing to market new drugs.



Detrol, the drug involved in this 2011 case, was advertised to men with swollen prostates and other bladder related conditions. However, the medicine was not approved for these cases and was actually for leaking problems and the need to urinate more often than usual.



Pfizer Inc. denies the accusations and admits to settling as a way to avoid ‘the cost and distraction of litigation.’



The payment to the government of $14.5 million will be divided among state Medicaid programs and the federal government. Whistleblowers who reported the wrong doing by the pharmaceutical company, will receive $3.2 million from the governments share.



The latest settlement was announced last Friday by the U.S. Attorney’s office, Boston.

If you or someone you know have had a similar experience with a drug recall or any other legal matter, please don’t hesitate to contact Vincent Shannon at Shannons Solicitors in Swords and visit Drug Recalls Europe to find a lot of information that can help you on the matter of recalls and defects.